Empowerment-based Complementary and Alternative Medicine (ECAM)

Not Applicable

Completed

• Conditions: Diabetes
• Interventions: Other: Written Paper for CAM Health Education

• Registration Number: NCT06317584
• Lead Sponsor: Chang Gung University of Science and Technology

Brief Summary

This phase study will use a randomized trial method to evaluate the performance of the ECAM educational app in the promotion of CAM health literacy and communication among patients with diabetes.

Detailed Description

The objectives of this phase study are to (1) implement the ECAM educational app to empower patients with diabetes in their management of diabetes alongside CAM use; (2) examine the impact of the ECAM educational app on patient empowerment, CAM health literacy, risk management of CAM use, CAM communication and diabetes quality of life in patients with diabetes; and (3) collect feedback from both patients and nurses on how to improve the ECAM educational app for dissemination and implementation.

Study Timeline

• Study First Submitted: 2024-03-12
• Study First Submitted QC: 2024-03-12
• Study First Posted: 2024-03-19
• Study Start: 2024-05-17
• Primary Completion: 2024-08-16
• Study Completion: 2025-01-03
• Status Verified: 2025-03
• Last Update Submitted: 2025-03-26
• Last Update Posted: 2025-04-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

• People over the age of 20
• diagnosis of diabetes at least 12 months before the interview; and
• The use of CAM at least 3 months
• Sufficient mental ability to understand the informed consent form and sign it.

Exclusion Criteria

• Participants will be excluded by an assistant researcher if they serious physical condition and hard of hearing and seeing.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Written Paper for CAM Health Education.	Written Paper for CAM Health Education	Using written paper for complementary and alternative therapy education, explaining the risk factors that need to be considered

Primary Outcome Measures

Name	Time	Method
Understanding the benefits-risks of complementary therapies (CTs) use scale Alternative Medicine (CAM) use questionnaire	Pre-test (baseline), 2, 3 months after intervention	Measure patients' understanding of benefit-risk management on CAM use，The lower the score, the poorer the understanding.
Quality of life questionnaire	Pre-test (baseline), 2, 3 months after intervention	assess patients' satisfaction with various aspects of life while managing diabetes.
Diabetes Empowerment scale	Pre-test (baseline), 2, 3 months after intervention	Measure patients' understanding of benefit-risk management on CAM use, the minimum and maximum values，and higher scores .The minimum is 10，maximum values is 40，The lower the score, the poorer the understanding.

Trial Locations

Locations (1)

CHENG GUNG MEMORIAL HOSPITAL, Linkou; 🇨🇳 Taoyuan City, Guishan District, Taiwan